Reporting incidental findings of genomic disorder-associated copy number variants to unselected biobank participants

Procedural guidelines for disclosure of incidental genomic information are lacking. We introduce a method and evaluated the impact of returning results to population biobank participants with 16p11.2 copy number variants, which are commonly associated with neurodevelopmental disorders and BMI imbala...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Personalized medicine Ročník 13; číslo 4; s. 303
Hlavní autoři: Leitsalu, Liis, Alavere, Helene, Jacquemont, Sébastien, Kolk, Anneli, Maillard, Anne M, Reigo, Anu, Nõukas, Margit, Reymond, Alexandre, Männik, Katrin, Ng, Pauline C, Metspalu, Andres
Médium: Journal Article
Jazyk:angličtina
Vydáno: England 01.07.2016
Témata:
ISSN:1741-0541, 1744-828X, 1744-828X
On-line přístup:Zjistit podrobnosti o přístupu
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Procedural guidelines for disclosure of incidental genomic information are lacking. We introduce a method and evaluated the impact of returning results to population biobank participants with 16p11.2 copy number variants, which are commonly associated with neurodevelopmental disorders and BMI imbalance. Of the 7877 participants, 11 carriers were detected. Eight participants were informed of their carrier status and surveyed 11-17 months later. All participants demonstrated preference for disclosure. Although two participants experienced worry, all five survey respondents rated receiving this information favorably. One participant reported modifications in treatment and three felt that their treatment/condition had since improved. This approach can be adapted and applied for the return of incidental findings to biobank participants.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1741-0541
1744-828X
1744-828X
DOI:10.2217/pme-2016-0009